chr5-72989496-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_138782.3(FCHO2):ā€‹c.195A>Cā€‹(p.Gln65His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000325 in 1,599,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000059 ( 0 hom., cov: 33)
Exomes š‘“: 0.000030 ( 0 hom. )

Consequence

FCHO2
NM_138782.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.443
Variant links:
Genes affected
FCHO2 (HGNC:25180): (FCH and mu domain containing endocytic adaptor 2) Enables identical protein binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in clathrin-coated pit and clathrin-coated vesicle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022460759).
BS2
High AC in GnomAd4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FCHO2NM_138782.3 linkuse as main transcriptc.195A>C p.Gln65His missense_variant 3/26 ENST00000430046.7 NP_620137.2 Q0JRZ9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FCHO2ENST00000430046.7 linkuse as main transcriptc.195A>C p.Gln65His missense_variant 3/261 NM_138782.3 ENSP00000393776.2 Q0JRZ9-1
FCHO2ENST00000287761.7 linkuse as main transcriptc.195A>C p.Gln65His missense_variant 3/111 ENSP00000287761.6 H7BXJ4
FCHO2ENST00000512348.5 linkuse as main transcriptc.195A>C p.Gln65His missense_variant 3/252 ENSP00000427296.1 Q0JRZ9-3
FCHO2ENST00000507345.6 linkuse as main transcriptc.126-982A>C intron_variant 5 ENSP00000426842.2 H0YAE2

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000886
AC:
20
AN:
225834
Hom.:
0
AF XY:
0.000107
AC XY:
13
AN XY:
121244
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000956
Gnomad SAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000177
GnomAD4 exome
AF:
0.0000297
AC:
43
AN:
1447284
Hom.:
0
Cov.:
30
AF XY:
0.0000390
AC XY:
28
AN XY:
718240
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000533
Gnomad4 SAS exome
AF:
0.000156
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000150
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00116
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000340
ExAC
AF:
0.000124
AC:
15

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 10, 2024The c.195A>C (p.Q65H) alteration is located in exon 3 (coding exon 3) of the FCHO2 gene. This alteration results from a A to C substitution at nucleotide position 195, causing the glutamine (Q) at amino acid position 65 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0035
T;.;T
Eigen
Benign
-0.055
Eigen_PC
Benign
-0.024
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.81
T;T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.022
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
M;M;.
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-1.7
N;N;D
REVEL
Benign
0.13
Sift
Benign
0.24
T;T;T
Sift4G
Benign
0.14
T;T;T
Polyphen
1.0
D;.;.
Vest4
0.39
MutPred
0.50
Loss of MoRF binding (P = 0.1036);Loss of MoRF binding (P = 0.1036);Loss of MoRF binding (P = 0.1036);
MVP
0.52
MPC
0.28
ClinPred
0.087
T
GERP RS
2.7
Varity_R
0.49
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs578172606; hg19: chr5-72285323; COSMIC: COSV105156968; API